Biopharma Analyst Chen, along with CMO Puhlmann and CSO Schultz discuss the competitive advantages of the company’s key pipeline assets in a webinar to be held on September 9 at 1 pm hosted by Cantor Fitzgerald. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CATX:
- Mark Austin Steps Down from Executive Roles at Perspective Therapeutics
- Perspective Therapeutics to Participate in Upcoming Investor Conferences in September
- Perspective Therapeutics Announces Executive Financial Reorganization
- Perspective Therapeutics price target lowered to $27 from $29 at RBC Capital
- Perspective Therapeutics price target lowered to $17 from $19 at Oppenheimer